CHRS CIK: 1512762

Coherus Oncology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
269
FY22:
141
FY23:
98.3
FY24:
17.7
FY25:
28.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−264
FY22:
−257
FY23:
−203
FY24:
−200
FY25:
−181
(positive)
Change from FY21 to FY25
millions USD
FY21:
−261
FY22:
−249
FY23:
−194
FY24:
–
FY25:
−170
(positive)
Change from FY21 to FY25
millions USD
FY21:
−287
FY22:
−292
FY23:
−238
FY24:
−215
FY25:
−183
(positive)
Change from FY21 to FY25
millions USD
FY21:
−287
FY22:
−292
FY23:
−238
FY24:
28.5
FY25:
168

All amounts in millions USD Data sources:SEC EDGARTwelve Data